Doxycycline hyclate

盐酸多西环素

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameDoxycycline hyclate
Drug Alias NameDoxycycline Hydrochloride盐酸强力霉素Doxycyclinum海克多西环素Doxiciclina +[32] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitorsMatrix metalloproteinase inhibitors
Targets30S ribosomal subunitMatrix metalloproteinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Chronic Knee PainSolid tumours +[62] 
Global Approved IndicationsUrethritisRespiratory Tract InfectionsTetanus +[16] 
Approved Indications in ChinaTetanusScrub TyphusChancroid
Original Approved Country/TerritoryUnited States
Original Approved Date1967/12/05
Country/TerritoryCanadaUnited StatesSingapore +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoSwiss Cancer InstituteUniversity Malaysia Sabah +[19] 
Inactive CompaniesCampbell ClinicUniversity of Sao PauloFeinstein Institute For Medical Research +[22] 
Active IndicationsSolid tumoursSeromaRosacea +[28] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Chronic Knee PainCytokine Release Syndrome +[34] 

Other Information

ATC CodeA01AB22J01AA02
Related LinksWikipediaDrugBankKEGG